AskBio, a subsidiary of Bayer (BAYN GY), announces FDA acceptance of a IND application for AB-1009 gene therapy being developed for the treatment of late-onset Pompe disease
Importance
Level 1
#GERMANY#EUROPE#BAYER AG#BAYN.GY#FDA#EQUITIES#EU SESSION#US SESSION#PHARMACEUTICALS#PHARMACEUTICALS (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#BAYN#EURO STOXX 50#DAX 40 INDEX